(资料图片)
步长制药近期接受投资者调研时称，安宫牛黄丸药品相关技术正式受让后有利于拓展公司业务，丰富公司产品线，加强市场竞争力，预计市场潜力较好，但药品未来的具体销售情况可能受到市场环境变化等因素影响，具有不确定性风险。
(资料图片)
步长制药近期接受投资者调研时称，安宫牛黄丸药品相关技术正式受让后有利于拓展公司业务，丰富公司产品线，加强市场竞争力，预计市场潜力较好，但药品未来的具体销售情况可能受到市场环境变化等因素影响，具有不确定性风险。
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-06-01
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-31
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30
2023-05-30